HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Arginine vasopressin in vasodilatory shock: a new therapy approach?].

Abstract
Catecholamines are currently the most often used vasopressor agents in the treatment of vasodilatory shock. However, progressive catecholamine resistance is a feared complication. Recent studies have shown that arginine vasopressin, an endogenous hormone of the neurohypophysis, may be a potent vasopressor when used in combination with catecholamines. During catecholamine-resistant septic and postcardiotomy shock, argine vasopressin results in a significant increase in mean arterial pressure as well as a significant decrease in heart rate and vasopressor requirements. In the guidelines of both the "American Heart Association" and the "International Liaison Committee on Resuscitation" from the year 2000, arginine vasopressin is recommended as a possibly helpful agent in therapy refractory vasodilatory septic shock. There is currently limited data on possible side effects of a continuous arginine vasopressin therapy in vasodilatory shock. Therefore, arginine vasopressin should be restricted to patients where adequate stabilization of hemodynamic function cannot be achieved by conventional vasopressor therapy alone.
AuthorsM Dünser, V Wenzel, A J Mayr, W R Hasibeder
JournalDer Anaesthesist (Anaesthesist) Vol. 51 Issue 8 Pg. 650-9; discussion 659-60 (Aug 2002) ISSN: 0003-2417 [Print] Germany
Vernacular TitleArginin-Vasopressin im vasodilatatorischen Schock Ein neuer Therapieansatz?
PMID12391525 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Catecholamines
  • Receptors, Vasopressin
  • Vasoconstrictor Agents
  • Arginine Vasopressin
Topics
  • Arginine Vasopressin (adverse effects, therapeutic use)
  • Catecholamines (adverse effects, therapeutic use)
  • Drug Therapy, Combination
  • Hemodynamics (drug effects, physiology)
  • Humans
  • Receptors, Vasopressin (drug effects, physiology)
  • Shock (drug therapy, physiopathology)
  • Vasoconstrictor Agents (adverse effects, therapeutic use)
  • Vasodilation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: